Coastal Investment Advisors, Inc. Atara Biotherapeutics, Inc. Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$5.69 - $17.78 $19,915 - $62,230	-3,500 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$10.89 - $16.79 $2,559 - $3,945	-235 Reduced 6.29%	3,500 $49,000
Q3 2019 Oct 18, 2019	SELL	$12.03 - $19.94 $4,210 - $6,979	-350 Reduced 8.57%	3,735 $52,000
Q2 2019 Aug 01, 2019	BUY	$19.05 - $41.04 $10,191 - $21,956	535 Added 15.07%	4,085 $82,000
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $100,820 - $148,177	3,550 New	3,550 $142,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.